BlueSphere Bio presented a poster describing its TCXpress and iTCXpress high-through platforms for TCRs.

The day you’ve been waiting for has arrived. It’s time to meet the 2022 honorees of the BostInno Fire Awards.

What patients say they are feeling is also a possible source of confusion. Amit Etkin, the CEO of Alto Neuroscience, points out that in Asia the symptoms that Western psychiatry uses to diagnose depression—low moo

Michelle Mellion, M.D., newly-appointed SVP and head of clinical development at PepGen, began her career working to deliver the best possible to care to patients and education to medical students. Now she is working to ensure the patient’s voice is heard throughout the drug development process.

More than two years after Pfizer tied the knot with machine learning firm CytoReason in an AI-focused deal, the two companies have agreed to keep the partnership alive for at least five more years.

NEW YORK – Elicio Therapeutics said Tuesday that it received a $2.8 million grant from the Gastro-Intestinal Research Foundation in Chicago that it will use to develop two cancer vaccines.

Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point.

The Founder of the Sepsis Alliance, Carl Flatley, is on a mission to raise awareness for sepsis, and he is doing so by riding his bike across the state of Florida to honor his daughter, Erin, who passed away because of sepsis.